✦ LIBER ✦

Radiation Therapy Oncology Group 0521: A Phase III Randomized Trial of Androgen Suppression and Radiation Therapy Versus Androgen Suppression and Radiation Therapy Followed by Docetaxel/Prednisone for Localized, High-Risk Prostate Cancer

✍ Scribed by Asmita R. Patel; Howard M. Sandler; Kenneth J. Pienta

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6-Month Androgen Suppression Plus Radiat

✍ WALSH, P 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 55 KB

34 Phase 2 study of neoadjuvant docetaxe

✍ M. McKenzie; K. Chi; A. Neville; S. Ellard; B. Baerg; D. Ruether; E. Winquist; R 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Phase III Trial Comparing Whole-Pelvic V

✍ Roach, M. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 104 KB

Radiation Therapy Oncology Group 9910: P

✍ Pisansky, T.M.; Hunt, D.; Gomella, L.G.; Amin, M.B.; Balogh, A.G.; Chinn, D.M.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Phase I study of concurrent weekly docet

✍ Ronald C. Chen; Julian G. Rosenman; Leroy G. Hoffman; Wing-Keung Chiu; Andrew Z. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Concurrent and adjuvant docetaxel with t

✍ Michel Bolla; Jean Michel Hannoun-Levi; Jean-Marc Ferrero; Philippe Maingon; Joë 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 276 KB